Amgen To Buy Roche Rights to Neutropenia Drugs from Roche In 100 Markets

AMGen Corporate Logo, 1983

AMGen Corporate Logo, 1983 (Photo credit: Wikipedia)

Amgen is acquiring Roche‘s rights to the neutropenia drugs filgrastim and pegfilgrastim in approximately 100 markets outside the United States, effective January 1, 2014, for an undisclosed price.

Filgrastim and pegfilgrastim are marketed by Amgen in the United States and Europe under the trade names Neupogen® and Neulasta®, respectively. Since 1989, Roche has held the rights to filgrastim and pegfilgrastim under license from Kirin-Amgen, a joint venture between Amgen and Japan’s Kirin Holdings, in Eastern Europe, Latin America, Asia, the Middle East, and Africa.

In those regions of the world, filgrastim and pegfilgrastim generated a combined approximately $200 million in sales last year. Roche had not disclosed sales for either drug last year or earlier this year.

The drugs are designed to reduce the risk of infection in patients receiving chemotherapy by boosting white blood cell counts.

Japan’s Kyowa Hakko Kirin will continue to retain product rights and to market filgrastim and pegfilgrastim in parts of Asia, including China and Japan.

Our Hearts Go Out to the Victims and Families of the DC Navy Yard Tragedy

Map of Washington Navy Yard

Map of Washington Navy Yard (Photo credit: Wikipedia)

Our hearts go out to the victims and families of the DC Navy Yark tragedy on September 17, 2013.

Washington DC has many good things:  monuments, an educated work force, and alot of people who want to do good for others by serving in government.  However, there is a dark side to Washington DC.

Yesterday exposed that dark side, where the system of elaborate security and background checking overlooked and, even gave privileged access to, a seriously mentally disturbed individual who needlessly gunned down dedicated public servants at the Washington Navy Yard.

Janice Orlowski: Doesn't she care about Ariana-Leilani, too?

The gunman, Aaron Alexis, had a history of hearing voices.  He had even been seen by the VA hospital in Washington DC only a month ago — the same hospital where Ariana-Leilani’s father works as a “physician”  and who is failing to take proper care of Ariana-Leilani’s Severe Chronic Neutropenia.    The qualifications for being a physician at a VA hospital are pathetically low, hence the low quality care.  Isn’t it ironic that Dr. Janice Orlowski, who spoke to the press for the Medstar Washington Medical Center, expressed such sympathy for the victims of the shooting, but has shown no sympathy for Ariana-Leilani when Ariana-Lelani’s situation came before Dr. Orlowski as a conflicted member of the Board of Medicine of Washington DC.

We already have 13 people dead because the failings of the VA Hospital and Washington DC to recognize and treat mental illness in one individual.   Will Ariana-Leilani be next victim due to the failings of these institutions?

Sign the petition to help save Ariana-Leilani.

GoPetition for ariana-leilani

What would you do if 10 year old Ariana-Leilani were your child?

GoPetition for ariana-leilani

Make sure she gets the help she needs before it is too late.

Read more:

Question of the Day: Is a Medical Experiment on Ariana-Leilani a Matter of “National Security?”

Graph Showing Worsening Neutropenia Condition of Ariana-Leilani

Worsening Neutropenia Condition of Ariana-Leilani

By all indications, the failure of the USA to 10 year old Ariana-Leilani’s Severe Chronic Neutropenia with the life saving neupogen medicine she needs to boost her critically low ANC to protect her from potentially fatal infection has all the trappings of the medical experiments that hospitals like Medstar Georgetown University Hospital have conducted for the CIA in the past in the name of “National Security.”    Her ANC’s (the measure of her resistance to infection)  continue to be severely low (see graph), yet after five years no toxicology tests have been done to eliminate its cause, and Medstar Georgetown University Hospital continues to engage in this apparent medical “experiment” placing Ariana-Leilani at risk of fatal infection.

Seal of the C.I.A. - Central Intelligence Agen...The recent revelations of the USA’s collection of massive amounts of personal data on its own USA citizens using the FISA court and PRISM programs, in violation of the US Constitution’s right to privacy, and President Obama’s proclamation  today that this wholesale invasion of privacy is “legal” — despite direct conflict with the right to privacy in the USA are very disturbing.

Ariana-Leilani and Willi King

Ariana-Leilani and Willi King

Is this medical experiment by these DC based CIA affiliated institutions also being allowed as a matter of “national security” like the Tuskegee and MK-ULTRA experiments of the past?   Voice your outrage.   Sign the petition to save Ariana-Leilani.

Sign the petition to Save Ariana-Leilani: 


On the Air: The Word of Ariana-Leilani’s Call for Help Is Being Heard

The story of Ariana-Leilani’s plight continues to spread.    Two recent radio programs that featured her story and call for help:

Listen how Ariana-Leilani is not getting needed medicine for her neutropenia, then please sign her petition:



Study: Hospitals ‘Profit Handsomely’ From Surgical Errors


JAMA (Photo credit: kimubert)

A recent study in the JAMA, shows that hospitals profit from surgical errors.

Hospitals nearly triple their profits when they make surgical errors, compared to how much they make when patients don’t suffer harm, according to a new study published in the Journal of the American Medical Association (JAMA).

On average, the hospitals studied reaped an extra $30,500 in profits when a patient developed one or more potentially preventable surgical complications because insurance plans pay more for longer stays and extra care, the study found.

Some surgical mishaps boosted profits by up to $44,000 per patient, reported researchers from the Boston Consulting Group, Harvard, and Texas Health Resources, a large nonprofit hospital system.

The occurrence of postsurgical complications was associated with a higher per-encounter hospital contribution margin for patients covered by Medicare and private insurance but a lower one for patients covered by Medicaid and who self-paid. Depending on payer mix, many hospitals have the potential for adverse near-term financial consequences for decreasing postsurgical complications.

Read more: Hospitals Profit from Errors

Relationship Between Occurrence of Surgical Complications and Hospital Finances

Related articles